Fortis Hospital, Noida and International Oncology Cancer Center organise IOCON 2013

Fortis Hospital Noida, along with International Oncology Cancer Center and Montefiore Cancer Center, New York organised an international conference on ‘Changing Scenario in Gynecological Malignances’: IOCON-2013 at the Indian Habitat Centre, New Delhi. The conference was reportedly attended by well-known experts in the field of medical, radiation and surgical oncologists along with gynaecologists and other speciality doctors. The objective of this one day conference was to discuss and share the current evidence based standards and emerging concepts in oncology cancer.

Various relevant and pertinent aspects related to management of gynaecological cancers and on prevention, screening, treatment modalities like radiation therapy, chemotherapy and surgery and rehabilitation were discussed with emphasis on bringing newer advances in technology into the realm of modern clinical practice. The conference also featured multi-speciality panel discussions on various aspects of treatment reflecting the importance of multi-disciplinary management of these cancers.

Sukhmeet Sandhu, Zonal Director, Fortis Healthcare commented, “There has been a significant advancement in cancer research and management over past few decades yet; it still remains a leading cause of death worldwide. Our endeavor is to raise awareness and educate people on how cancer can be cured and on the importance of an early detection.”

Speaking on the occasion, Pradeep Jai Singh, MD & CEO, International Oncology said, “Being a center of excellence in gynaecological malignancies, the conference is an effort and reiteration of our commitment towards prevention and screening of cancers. We hope to make more consumers aware of this disease and its management at the various stages in a positive approach.”

“Gynaecological cancers are highly prevalent in our society collectively making 40-50 per cent of cancer affecting the female population. Cancer of cervix, ovaries and uterine cancers are the three of top five cancers that affect women in India of which cancer of the cervix is the most common. With advancements in new technologies, a higher cure rates can be expected,” he added.

The Scientific Committee of IOCON – 2013 emphasised that the gynaecological cancers comprise the bulk of cancer burden in our country but with the implementation of state-of-the-art treatment technologies, higher cure rates can be expected.

EH News Bureau